Turnstone rejigs staff and exec team, eases preclinical work as cash runs low

Just over a year af­ter go­ing pub­lic, Turn­stone Bi­o­log­ics is ax­ing staff, ad­just­ing its lead­er­ship team and chang­ing its pipeline fo­cus to ex­tend its cash …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.